Resurrecting treatment histories of dead patients - A study design that should be laid to rest

被引:211
作者
Bach, PB [1 ]
Schrag, D [1 ]
Begg, CB [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Hlth Outcomes Res Grp, Dept Epidemiol & Biostat, New York, NY 10021 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 292卷 / 22期
关键词
D O I
10.1001/jama.292.22.2765
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this article we address whether studies of care rendered to patients prior to their death ("studies of decedents") produce an accurate portrait of care provided to patients who are dying. Studies of decedents typically analyze the care provided to patients over a defined interval antecedent to death. Studies of dying patients analyze care provided to patients subsequent to the time that their terminal status is perceived. We address whether 2 fundamental differences between studies of decedents and studies of the dying-the Ways that subjects are identified and the time periods that are examined-lead to differences in interpretation of study results. Using examples from population-based cohorts of individuals with cancer, we show that both the differences in subject selection and time period introduce very substantial biases into studies of decedents. We conclude that studying care received prior to death can lead to invalid conclusions about the quality or type of care provided to dying patients.
引用
收藏
页码:2765 / 2770
页数:6
相关论文
共 35 条
[1]   Outcomes and resource utilization for patients with prolonged critical illness managed by university-based or community-based subspecialists [J].
Bach, PB ;
Carson, SS ;
Leff, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (05) :1410-1415
[2]  
Bird Chloe E, 2002, J Palliat Med, V5, P705, DOI 10.1089/109662102320880525
[3]  
Christakis N A, 1998, Hosp J, V13, P71
[4]   Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study [J].
Christakis, NA ;
Lamont, EB .
BRITISH MEDICAL JOURNAL, 2000, 320 (7233) :469-472
[5]  
Collett D, 2014, MODELLING SURVIVAL D
[6]   Identifying potential indicators of the quality of end-of-life cancer care from administrative data [J].
Earle, CC ;
Park, ER ;
Lai, B ;
Weeks, JC ;
Ayanian, JZ ;
Block, S .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) :1133-1138
[7]   Impact of referral patterns on the use of chemotherapy for lung cancer [J].
Earle, CC ;
Neumann, PJ ;
Gelber, RD ;
Weinstein, MC ;
Weeks, JC .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1786-1792
[8]   Trends in the aggressiveness of cancer care near the end of life [J].
Earle, CC ;
Neville, BA ;
Landrum, MB ;
Ayanian, JZ ;
Block, SD ;
Weeks, JC .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :315-321
[9]   Chemotherapy use among medicare beneficiaries at the end of life [J].
Emanuel, EJ ;
Young-Xu, Y ;
Levinsky, NG ;
Gazelle, G ;
Saynina, O ;
Ash, AS .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (08) :639-643
[10]   Managed care, hospice use, site of death, and medical expenditures in the last year of life [J].
Emanuel, EJ ;
Ash, A ;
Yu, W ;
Gazelle, G ;
Levinsky, NG ;
Saynina, O ;
McClellan, M ;
Moskowitz, M .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (15) :1722-1728